Integral Derivatives’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$992K Buy
11,900
+6,900
+138% +$622K 0.02% 239
2017
Q4
$474K Buy
5,000
+2,400
+92% +$251K 0.01% 735
2017
Q3
$304K Sell
2,600
-16,300
-86% -$2.06M 0.01% 888
2017
Q2
$2.38M Buy
18,900
+13,100
+226% +$1.67M 0.05% 267
2017
Q1
$775K Buy
5,800
+3,600
+164% +$458K 0.01% 603
2016
Q4
$221K Buy
+2,200
New +$215K ﹤0.01% 974

Other funds holding INCY

Integral Derivatives's INCY Position: Q1 2018 in Review

Integral Derivatives sold out of Incyte (INCY) in Q1 2018, closing a stake of 3,675 shares — an estimated $331K sold.

Integral Derivatives first reported a position in INCY in Q1 2017 and held it in 2 quarters. The position peaked at $348K in Q4 2017. 499 funds tracked by Wall St. Rank hold INCY as of Q1 2018.

  • Integral Derivatives reported no remaining Incyte position as of Q1 2018 after selling out during the quarter.
  • Integral Derivatives sold 3,675 Incyte shares in Q1 2018, an estimated $331K.
  • Integral Derivatives first reported a position in Incyte in Q1 2017 and held it in 2 quarters.
  • Integral Derivatives's Incyte position peaked at $348K in Q4 2017.
  • 499 funds tracked by Wall St. Rank held Incyte as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.